EXEL Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
658.7M
+4.8%
628.7M
+2.9%
610.8M
+2.0%
598.7M
+0.2%
597.8M
Cost of Revenue
26.2M
+27.0%
20.7M
+3.5%
20.0M
-24.7%
26.5M
+42.6%
18.6M
Gross Profit
632.5M
+4.0%
608.0M
+2.9%
590.9M
+3.3%
572.2M
-1.2%
579.2M
Operating Expenses
364.0M
+1.2%
359.6M
+5.9%
339.5M
+0.8%
337.0M
-1.7%
342.6M
R&D
209.5M
-1.2%
212.0M
+6.0%
199.9M
-6.3%
213.2M
+7.1%
199.2M
SG&A
154.6M
+4.7%
147.6M
+5.8%
139.6M
+13.5%
123.0M
-0.5%
123.7M
Operating Income
268.4M
+8.1%
248.4M
-1.2%
251.3M
+6.9%
235.2M
-0.6%
236.5M
EBITDA
275.4M
+7.8%
255.4M
-1.1%
258.3M
+6.4%
242.9M
-7.9%
263.8M
Net Income
218.1M
+2.9%
212.1M
+0.8%
210.5M
-13.9%
244.5M
+26.3%
193.6M
EPS (Basic)
$0.88
+3.5%
$0.85
+4.9%
$0.81
-12.0%
$0.92
+27.8%
$0.72
EPS (Diluted)
$0.85
+3.7%
$0.82
+3.8%
$0.79
-10.2%
$0.88
+27.5%
$0.69
Shares (Diluted)
255.8M
-1.5%
259.7M
-2.9%
267.3M
-3.3%
276.3M
-0.8%
278.5M
Exelixis (EXEL) — Financials